Healthtech Startups

Enzene Biosciences is a biologics company focused on the development and manufacturing of biopharmaceuticals. It is a subsidiary of Alkem Laboratories and offers advanced manufacturing processes as a strategic partner for biologic products.

1 investor

1 investor

Enzymatica develops health products that support the body's natural defenses against viruses, irritants, and microorganisms, including its ColdZyme mouth spray for treating and shortening the common cold. The company operates in the consumer healthcare and life sciences sector.

1 investor

Enzymlogic provides kinetic profiling of compounds to support early-stage drug discovery, focusing on the Hit to Lead and Lead Optimization phases. Using protein science and high-throughput screening assays, it delivers kinetic data on compound-target interactions to pharmaceutical and biotech organizations to help them prioritize promising molecules.

1 investor

Eodyne offers the RGS Ecosystem, an AI-based rehabilitation platform that supports neurorehabilitation and hip/knee replacement recovery across hospital, clinic, and home settings. It serves patients and rehabilitation professionals, aligning therapy with clinical guidelines to improve functional recovery and treatment adherence.

1 investor

Eon Health provides a platform for detecting and managing lung cancer early, helping healthcare systems identify and track pulmonary nodules to improve patient outcomes. The solution serves hospitals and healthcare networks seeking to improve early cancer detection through systematic care management.

1 investor

Eos is a healthcare data integration platform that connects disconnected clinical and operational systems (EHRs, imaging, labs, scheduling, billing) to create unified patient records while keeping data in original systems. The platform resolves patient identities across sites and encounters for healthcare organizations.

1 investor

Eos SENOLYTIX develops senolytic peptides designed to restore cellular balance in aged or senescent cells across body organs, focusing on gerotherapeutics. The company targets age-related conditions through proprietary approaches to cellular rejuvenation.

1 investor

Eos BioInnovation invests in early-stage regenerative medicine therapies and technologies, focusing on cell, gene, and tissue therapies that target disease causes. The firm partners with researchers and entrepreneurs to accelerate the translation of breakthrough science into commercial biotech companies.

1 investor

EoScene builds cloud-based software for managing environment-of-care safety, quality, and compliance in healthcare facilities, automating assessments, temperature monitoring, and readiness tasks. Its tools serve hospitals and other healthcare providers, though they can be adapted to other facilities with compliance needs.

1 investor

Epic develops electronic health record software used across healthcare organizations including hospitals, clinics, dental practices, and payers to help patients manage, maintain, and improve their health over time. The company serves the broader healthcare ecosystem including academic medical centers, community hospitals, specialty practices, and life sciences organizations.

1 investor

Epicyt Pharma is a pharmaceutical R&D company developing treatments focused on intestinal calcium absorption and its effect on bone health, with its lead candidate BAFA aimed at restoring calcium uptake and preventing osteoporosis. The company is based in Gothenburg, Sweden.

1 investor

Epidutech develops an AI-powered surgical navigation platform for spine surgery that uses a patented "magnetic camera" attached to the patient's body to track a permanent magnet embedded in surgical tools in real time. It targets hospitals, clinics, and Ambulatory Surgery Centers (ASCs), replacing bulky hardware-based navigation with a compact, brand-agnostic software approach.

1 investor

EpiEndo Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for chronic respiratory diseases such as COPD, based on research into macrolides and their effects on the lung epithelium. Its lead program, EP395 (glasmacinal), is a non-antibacterial macrolide with anti-inflammatory activity that is Phase 2b ready.

1 investor

EpiEP develops the EpiAccess System, a pressure-guided needle used with standard fluoroscopy to give physicians real-time confirmation of access into the pericardial cavity for epicardial heart procedures. The technology supports treatments such as ventricular tachycardia, atrial fibrillation, and left atrial appendage ligation, and serves cardiac electrophysiologists and interventional cardiologists.

1 investor

Epiphany Dermatology operates dermatology clinics staffed by board-certified dermatologists, physician assistants, nurse practitioners, and aestheticians, offering medical services such as skin cancer care, Mohs surgery, biopsies, and acne treatment, as well as cosmetic services like chemical peels, injectable fillers, and body contouring. It also sells physician-approved skin care products and aims to provide accessible dermatologic care across multiple U.S. locations.

1 investor

Epitomee Medical develops the Epitomee Capsule, a medical device for weight management solutions. The company brings together experts in medical technology and clinical research to address health outcomes.

1 investor

EpiVax works with biologic and vaccine developers to assess and manage immunogenicity risk across the product lifecycle, combining in silico analysis with in vitro testing to produce actionable immunogenicity data. The company helps pharmaceutical and vaccine partners reduce risk and build regulatory-ready strategies for safer therapies.

1 investor

EPOCA provides medical remote monitoring (télésurveillance) for seniors, including those with multiple unstable chronic conditions such as heart, respiratory, or renal failure and diabetes, to support safe care at home or in care facilities. Its approved medical device and dedicated care team enable 24/7 remote follow-up prescribed by physicians in France, aiming to reduce avoidable hospitalizations and readmissions.

1 investor

An integrated discovery platform for rapidly identifying high-quality VHH lead molecules from humanized libraries using cDNA display technology and developability assessment for drug research programs.

1 investor

EPTAM provides precision machining, plastics, and molding manufacturing services for regulated industries including medical and aerospace sectors. The company operates multiple facilities offering quality assurance and automated inspection capabilities.

1 investor

eQcell develops regenerative medicine therapies for veterinary use, aiming to treat animal conditions that are poorly addressed by current treatments. The company focuses on novel cell-based therapies to improve animal welfare.

1 investor

Equals 5 provides a healthcare marketing platform that enables pharmaceutical marketers to target physicians using NPI (National Provider Identifier) lists and measure engagement across multiple advertising channels. The platform combines audience data enrichment, privacy-compliant activation, and attribution tracking for healthcare provider outreach.

1 investor

This page is a financial analysis archive from Equasens' investor relations section, containing links to analyst reports and earnings commentary from various financial research firms.

1 investor